Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.61 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | ACLY | P53396 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
| ▸ | TERT | O14746 | 3/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.52 |
| ▸ | PPARG | P37231 | 3/20 | 0.52 |
| ▸ | PPARD | Q03181 | 3/20 | 0.52 |
| ▸ | PPARA | Q07869 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | BLM | P54132 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | FABP4 | P15090 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL119424 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL18248559 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL10805141 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL3844890 | 1.00 | FAAH (0.61) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL18248594 | 0.95 | KDM4E (0.65) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| Propylamine SCHEMBL28274365 | 0.93 | FAAH (0.54) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| Propylamine SCHEMBL28834642 | 0.93 | FAAH (0.54) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| Oleic Acid SCHEMBL9308139 | 0.91 | PPARG (0.70) | FAAHCYP1A2CYP2C19KMT2ACYP3A4 | |
| SCHEMBL373955 | 0.88 | FDPS (0.47) | — | |
| SCHEMBL547320 | 0.88 | FDPS (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240398751-A1 | Methods of treating or reducing symptoms of stimulant dependency (addiction) via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and glutamate allosteric modulators | HELDRETH JR DAVID ALAN (US) | 2024-12-05 | — | — | US | claimed |
| US-20240398750-A1 | Methods of treating or reducing symptoms of anxiety, depression, attention deficiency (ADD), attention deficient hyperactivity (ADHD), obsessive compulsive (OCD), Bipolar disorder, and related disorders/conditions via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and other allosteric modulators. | HELDRETH JR DAVID ALAN (US) | 2024-12-05 | — | — | US | claimed |
| US-20240325343-A1 | Methods of reducing symptoms of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, GLP-1 allosteric modulators where the method of delivery/formulation selected from: Inhaler, nebulizer, intravenously, intramuscularly, injection, capsules, tablets, pills. | HELDRETH JR DAVID ALAN (US) | 2024-10-03 | — | — | US | claimed |
| US-20240325345-A1 | Methods of increasing effects of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, opiate allosteric modulators as/in foods, beverages, vaporizer, smoking and supplement products/formulations. | HELDRETH JR DAVID ALAN (US) | 2024-10-03 | — | — | US | claimed |
| US-20240325342-A1 | Methods of treating or reducing symptoms of opiate dependency (addiction) via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and opiate allosteric modulators | HELDRETH JR DAVID ALAN (US) | 2024-10-03 | — | — | US | claimed |
| US-20240325344-A1 | Methods of reducing symptoms of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, GLP-1 allosteric modulators as/in foods, beverages, vaporizer, smoking and supplement products/formulations. | HELDRETH JR DAVID ALAN (US) | 2024-10-03 | — | — | US | claimed |
| US-20240299341-A1 | Methods of treating or reducing symptoms of nicotine dependency (addiction) such as tobacco-use (smoking, vaping, sublingual, oral) and/or tobacco smoking cessation via combination therapy with allosteric modulators and phenethylamines. | HELDRETH JR DAVID ALAN (US) | 2024-09-12 | — | — | US | claimed |
| US-20240269107-A1 | Methods of treating or reducing symptoms of brain cancer such as glioma and glioblastoma via combination therapy with allosteric modulators and phenethylamines. | HELDRETH JR DAVID ALAN (US) | 2024-08-15 | — | — | US | claimed |
| CN-111636068-B | Cleaning agent and preparation method thereof | 上海未来企业股份有限公司 | 2022-08-16 | — | — | CN | claimed |
| CN-114761637-A | Non-rewetting O/W (oil in water) emulsification systems for hydrophobic compounds | 有机点击股份公司 | 2022-07-15 | — | — | CN | claimed |
| EP-3297621-A1 | A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE | Dublin City University (IE) | 2018-03-28 | — | — | EP | claimed |
| WO-2016185025-A1 | A METHOD FOR TREATING PERIPHERAL INFLAMMATORY DISEASE | DUBLIN CITY UNIVERSITY (IE) | 2016-11-24 | — | — | WO | claimed |
| CN-102396519-A | Reptile killing aerosol | WEI JIANG | 2012-04-04 | — | — | CN | claimed |
| EP-1037677-A2 | MEDICAL DEVICES WITH IMPROVED PROPERTIES | Intella Interventional Systems, Inc. (US) | 2000-09-27 | — | — | EP | claimed |
| CN-1262601-A | Synergistic antimicrobial compositions containing dimethylamide of carboxylic acid with mixture of 2-(thiocyanomethylthio) benzothiazole and methylene-bis (thiocyanate) | BUCKMAN LABOR INC (US) | 2000-08-09 | — | — | CN | claimed |
| EP-0994651-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS CONTAINING A DIMETHYLAMIDE OF A CARBOXYLIC ACID WITH A MIXTURE OF 2-(THIOCYANOMETHYLTHIO) BENZOTHIAZOLE AND METHYLENE-BIS(THIOCYANATE) | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 2000-04-26 | — | — | EP | claimed |
| WO-1999029353-A2 | MEDICAL DEVICES WITH IMPROVED PROPERTIES | INTELLA INTERVENTIONAL SYSTEMS, INC. (US) | 1999-06-17 | — | — | WO | claimed |
| WO-1999002037-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS CONTAINING A DIMETHYLAMIDE OF A CARBOXYLIC ACID WITH A MIXTURE OF 2-(THIOCYANOMETHYLTHIO) BENZOTHIAZOLE AND METHYLENE-BIS(THIOCYANATE) | BUCKMAN LABORATORIES INTERNATIONAL, INC. (US) | 1999-01-21 | — | — | WO | claimed |
| CN-111636068-B | Cleaning agent and preparation method thereof | 上海未来企业股份有限公司 | 2022-08-16 | — | — | CN | disclosed |
| US-3954977-A | EMULSIFIERS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-05-04 | — | — | US | disclosed |